Sage Therapeutics Inc (SAGE)
8.31
+0.10
(+1.22%)
USD |
NASDAQ |
Mar 25, 11:05
Sage Therapeutics Profit Margin (Quarterly): -747.3% for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Biogen Inc | 10.86% |
| Moderna Inc | -117.2% |
| Johnson & Johnson | 15.24% |
| Intra-Cellular Therapies Inc | -8.48% |
| Cytokinetics Inc | -886.3% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -63.59% |
| Return on Assets | -56.97% |
| Return on Invested Capital | -63.59% |
| Gross Profit Margin (Quarterly) | 88.38% |
| Operating Margin (Quarterly) | -626.9% |
| Return on Net Operating Assets | -1.22K% |